The present work demonstrates how activation and expansion of NK cells in the presence of IL-2, IL-15 and the EBV+, HLA-I negative 721.221 cells clearly increases their cytotoxicity on cells from B-CLL patients. The gene discussed is IL2; the disease is B-cell chronic lymphocytic leukemia.